Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children

Nalla Anuraag Reddy; Alex Tom; Harsha P Lashkari

doi:10.1016/j.phoj.2021.12.004

Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children

Nalla Anuraag Reddy, Alex Tom, Harsha P Lashkari

Department of Paediatrics, Kasturba Medical College, Mangalore

Research output: Contribution to journal › Article › peer-review

Abstract

Corona Virus disease 2019 (COVID-19) pandemic has presented a huge challenge to the health care system in terms of magnitude of cases and to pediatric oncology units with varied clinical presentations. Acute myeloid leukemia(AML) is a rare heterogenous cancer of childhood with an induction mortality around 15% in our country due to neutropenic sepsis. Multisystem inflammatory syndrome in children(MIS-C) is an hyperinflammatory syndrome seen 4–6 weeks after COVID-19 infection. COVID infection in some of these children would have gone unnoticed. Here we report a two year eight months old boy diagnosed with AML on induction chemotherapy developed post COVID MIS-C

Original language	English
Pages (from-to)	1-10
Number of pages	10
Journal	Pediatric Hematology Oncology Journal
DOIs	https://doi.org/10.1016/j.phoj.2021.12.004
Publication status	Published - 21-12-2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.phoj.2021.12.004

Cite this

@article{d8465e186335443a9348363cde5027b5,

title = "Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children",

abstract = "Corona Virus disease 2019 (COVID-19) pandemic has presented a huge challenge to the health care system in terms of magnitude of cases and to pediatric oncology units with varied clinical presentations. Acute myeloid leukemia(AML) is a rare heterogenous cancer of childhood with an induction mortality around 15% in our country due to neutropenic sepsis. Multisystem inflammatory syndrome in children(MIS-C) is an hyperinflammatory syndrome seen 4–6 weeks after COVID-19 infection. COVID infection in some of these children would have gone unnoticed. Here we report a two year eight months old boy diagnosed with AML on induction chemotherapy developed post COVID MIS-C",

author = "Reddy, {Nalla Anuraag} and Alex Tom and Lashkari, {Harsha P}",

year = "2021",

month = dec,

day = "21",

doi = "10.1016/j.phoj.2021.12.004",

language = "English",

pages = "1--10",

journal = "Pediatric Hematology Oncology Journal",

issn = "2468-1245",

publisher = "Pediatric Hematology Oncology Chapter of Indian Academy of Pediatrics",

}

TY - JOUR

T1 - Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children

AU - Reddy, Nalla Anuraag

AU - Tom, Alex

AU - Lashkari, Harsha P

PY - 2021/12/21

Y1 - 2021/12/21

N2 - Corona Virus disease 2019 (COVID-19) pandemic has presented a huge challenge to the health care system in terms of magnitude of cases and to pediatric oncology units with varied clinical presentations. Acute myeloid leukemia(AML) is a rare heterogenous cancer of childhood with an induction mortality around 15% in our country due to neutropenic sepsis. Multisystem inflammatory syndrome in children(MIS-C) is an hyperinflammatory syndrome seen 4–6 weeks after COVID-19 infection. COVID infection in some of these children would have gone unnoticed. Here we report a two year eight months old boy diagnosed with AML on induction chemotherapy developed post COVID MIS-C

AB - Corona Virus disease 2019 (COVID-19) pandemic has presented a huge challenge to the health care system in terms of magnitude of cases and to pediatric oncology units with varied clinical presentations. Acute myeloid leukemia(AML) is a rare heterogenous cancer of childhood with an induction mortality around 15% in our country due to neutropenic sepsis. Multisystem inflammatory syndrome in children(MIS-C) is an hyperinflammatory syndrome seen 4–6 weeks after COVID-19 infection. COVID infection in some of these children would have gone unnoticed. Here we report a two year eight months old boy diagnosed with AML on induction chemotherapy developed post COVID MIS-C

U2 - 10.1016/j.phoj.2021.12.004

DO - 10.1016/j.phoj.2021.12.004

M3 - Article

SN - 2468-1245

SP - 1

EP - 10

JO - Pediatric Hematology Oncology Journal

JF - Pediatric Hematology Oncology Journal

ER -

Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this